Market Access VCs upbeat about European life sciences market, despite unce... It has been a curious start to the year for pharma and biotech investment.
R&D Investing in the gleams of positivity and hope for life scie... In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
